The Committee for Medicinal Products for Human Use recommends marketing approval for Merck's Keytruda for treating two types ...

The EMA CHMP has recommended approval of MSD’s KEYTRUDA for two gynaecological cancers: endometrial and cervical.

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S.Food and Drug Administration (FDA) ...

Maky Zanganeh became a billionaire after shares of Summit Therapeutics, where she serves as co-CEO, soared following positive ...

Non-muscle-invasive bladder cancer (NMIBC) is a type of bladder cancer where the tumor remains confined to the bladder's ...

Bob Duggan’s success shows you don’t need a Ph.D., or even a college education, to make money in the complex world of biotech ...

PDS Biotechnology's HPV-directed immunotherapy is sparking optimism in the biotech industry. Click here to find out why I am ...

The hygiene and health company Essity will publish its interim report for quarter 3, 2024 on October 24 at approximately 07:00 CET. President and CEO Magnus Groth and Executive Vice President and CFO ...

New anecdotal evidence suggests some chemoimmunotherapy treatments may improve pulmonary arterial hypertension symptoms, but the overall evidence remains murky.

The market for non-muscle-invasive bladder cancer (NMIBC) is anticipated to grow significantly, reaching $2.6b in 2023, with ...

Completion of the Gorge Rd has been long-awaited, since the 2017 road slips that led to the closure that has frustrated many ...

Today, the industry leader in wellness technology, Therabody, added five new innovations and four limited editions of bestselling products to their ecosystem of science-backed solutions. The latest ...